← Leaderboards
Hilary Elaine Nicholson
Dana-Farber Cancer Inst
$179,478
Attributed
$179,478
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $63.7K · FY2017–19$100K$75K$50K$25K$0
'17
'18
'19
Funding mix
By agency
NIH$179,478 · 1
By mechanism
F32$179,478 · 1
Top collaborators
No co-investigators on record.
Most similar at Dana-Farber Cancer Inst
Same institution · by research overlap
- Piotr Sicinski$42,703,610
- Jeffrey Wade Harper$36,219,392
- Bruce M Spiegelman$59,708,812
- Donald W. Kufe$50,160,456
- Nathanael Schiander Gray$36,761,550
Others in their field
Other Emerging Leaders on “Genetic Transcription”
- Evan Z Macosko · Broad Institute, Inc.$30,129,032
- Sonia Minikel Vallabh · Broad Institute, Inc.$14,507,691
- Tomasz Nowakowski · University Of California, San Francisco$12,105,692
- Chun Jimmie Ye · Feinstein Institute For Medical Research$11,595,683
- Yin Shen · University Of California, San Francisco$10,418,368
- Chongyuan Luo · University Of California Los Angeles$9,805,856
Research focus
Genetic TranscriptionGrowthGeneticCancer CellAngiogenesisCell DeathBiologyBaseCellsCellular TargetingCancer TherapyBiochemicalClustered Regularly Interspaced Short Palindromic RepeatsCombined Modality TherapyComplementCell KillingCell LineDiagnosisDoseDrosophila MelanogasterFitnessFoundationsGenesImplant
Grant awards (3)
Cross-species identification and validation of synthetic lethal relationships with VHL inactivation$63,746
F32 · FY2019 · CA · contact PI
Cross-species identification and validation of synthetic lethal relationships with VHL inactivation$59,038
F32 · FY2018 · CA · contact PI
Cross-species identification and validation of synthetic lethal relationships with VHL inactivation$56,694
F32 · FY2017 · CA · contact PI